RxDoctor Payments Data

Josef Shargorodsky, MD

Otolaryngology · Boston, MANPI 1659573384

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Stryker at 24.1% of the total.

$3,579in general payments, 2019–2025

Across 53 payments — averaging $67.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$863
  • Intersect ENT, Inc.$567
  • Optinose US, Inc.$413
  • Medtronic$400
  • AstraZeneca$342
  • Acclarent, Inc$340
  • plus $656 from 8 others

What the payments were for

  • Food & beverage$3,579100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,579 in reported general payments places this provider in the 80th percentile of 298 otolaryngology providers in Massachusetts.

See all otolaryngology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$287,142
Medicare patients
539
Services billed
1,721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide183$5,266
Fluticasone Propionate285$4,075
Sucralfate56$3,543
Azelastine Hcl118$2,103
Montelukast Sodium130$1,849
Ofloxacin24$884
Famotidine75$800
Mometasone Furoate52$738
Mupirocin121$627
Methylprednisolone62$384
Triamcinolone Acetonide14$290
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$246
Doxycycline Hyclate27$237
CefuroximeCefuroxime Axetil18$190
Prednisone39$154

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →